Gernot Riedel

Professor Gernot Riedel holds a Personal Chair at the University of Aberdeen's School of Medicine, Medical Sciences and Nutrition, within the Institute of Medical Sciences. His research focuses on neurodegenerative diseases, particularly Alzheimer’s and frontotemporal dementia, with an emphasis on tau protein aggregation, synaptic dysfunction, and drug development. He leads studies on tau aggregation inhibitors like hydromethylthionine and investigates their effects on cognitive and behavioral phenotypes in mouse models. Collaborating with global teams, his work integrates pharmacology, neuroimaging, and behavioral neuroscience to explore therapeutic targets and diagnostic tools. Key contributions include analyzing drug interactions, reproducibility in preclinical research, and the role of cholinergic systems in neuroprotection.

Publications highlight advancements in understanding tauopathies, alpha-synucleinopathies, and the impact of dietary interventions. His research also addresses methodological rigor in animal studies through initiatives like EQIPD. Professor Riedel’s lab employs cutting-edge techniques such as EEG monitoring, MRI analysis, and molecular biology to dissect disease mechanisms. Despite no explicit mention of formal student advisees, he collaborates extensively with postdoctoral researchers and international institutions. His work contributes to both foundational neuroscience and translational medicine.